Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 29 Jul 2026 for Oncology Institute, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Anne McGeorge: trading record in brief
Filings by Anne McGeorge span 3 companies, the busiest being Starling Oncology, Inc., Dianthus Therapeutics, Inc. /DE/ and SOC Telemed, Inc. The record holds 19 filings, for trades running from 5 January 2021 to 10 August 2026.
Every open-market trade on record is a sale: 5 sales worth €731k. Besides market trades, the filings include 11 share grants and 2 option exercises. 2026 to date brings no purchases and 5 sales.
The record was last updated on 11 August 2026 with an option exercise (€63k) in Dianthus Therapeutics, Inc. /DE/. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anne McGeorge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
41,165 shares0Common StockSEC:0001079973-26-000991:0
67,901 shares0Common StockSEC:0001553350-25-000148:0
56,000 shares0Common stockSEC:0001799191-24-000057:0
56,000 shares0Common stockSEC:0001628280-23-042818:0
26,247 shares0Common stockSEC:0001628280-23-008828:0
22,708 shares0Common StockSEC:0001799191-22-000036:0
58,387 shares@ US$3.00100.0% of flowClass A Common StockSEC:0001209191-22-023675:0
15,994 shares0Common stockSEC:0001628280-22-007093:0
21,067 shares0Class A Common StockSEC:0001209191-21-038698:0
9 of 9 declarations
